Travere Therapeutics, Inc. (NASDAQ: TVTX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRAVERE THERAPEUTICS, INC.

Travere Therapeutics, Inc. (NASDAQ: TVTX)
Listen to this Section


$45.06
+2.1040 ( +4.90% ) 913.9K

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.

Market Data


Open $45.06
Previous Close $42.96
Volume 913.9K
Market Cap $3.99B
Day Range $42.80 - $45.58
52 Week Range $13.88 - $48.61
Shares Outstanding 92.99M
Change % +4.90%
Net Change ▲ 2.1040
Insider Ownership -0.02%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: -218,171.00

Date Type Amount Purchased Purchaser
2024-05-10 Sale -6500.00 Meckler Jeffrey A
2024-05-10 Sale -6500.00 Squarer Ron
2024-05-10 Sale -6500.00 Poole Sandra
2024-05-10 Sale -6500.00 Orwin John A
2024-05-10 Sale -6500.00 LYONS GARY A
2024-05-10 Sale -6500.00 COUGHLIN TIMOTHY
2024-05-10 Sale -6500.00 Baynes Roy D.
2024-05-10 Sale -6500.00 Bruhn Suzanne Louise
2024-05-10 Sale -6500.00 Williams Brinkley Ruth
2024-04-12 Sale -54.00 Cline Christopher R.

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 06, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Nov 04, 2025
4 Insider transactions 1 Oct 30, 2025
10-q Quarterly Reports 95 Oct 30, 2025
8-k 8K-related 14 Oct 30, 2025
4 Insider transactions 1 Oct 30, 2025
4 Insider transactions 1 Sep 24, 2025
4 Insider transactions 1 Sep 24, 2025
8-k 8K-related 12 Sep 10, 2025

Latest News


× Before browsing our site, please accept our cookies policy